Israel’s Ministry of Health has granted regulatory approval for the sale of Aleph Farms’ lab-grown beef, known as Aleph Cuts. The approval, conveyed through a “No Questions” letter, allows the introduction of Aleph Cuts, starting with the Petit Steak, in Israel. The Petit Steak is composed of unmodified Black Angus cow cells and a plant protein matrix derived from soy and wheat. Aleph Farms, emphasizing terms like “cultivated” and “cell-based,” underscores their commitment to addressing food security challenges.

Aleph Farms CEO Didier Toubia commends Israel’s approach to cellular agriculture, viewing it as a means to ensure prosperity, particularly in regions heavily reliant on food imports. The company asserts that no antibiotics are used in the production process, emphasizing a controlled and traceable environment to enhance transparency and reduce contamination risks.

Yifat Gavriel, Chief of Regulatory Affairs at Aleph Farms, sees the approval as a significant step in the potential landmark year of 2024 for regulating and commercializing cultivated meat. The regulatory green light involves specific directions for labeling and marketing, along with a Good Manufacturing Practices (GMP) inspection for the pilot production facility.

Dr. Ziva Hamama, Director of the Food Risk Management Department at Israel’s Ministry of Health, highlights the comprehensive assessment undertaken during the regulatory process. This assessment covers factors such as toxicology, allergens, nutritional composition, microbiological safety, and chemical safety throughout the entire production process.

Bruce Friedrich, Founder and President of the Good Food Institute, hails the development as a critical leap in the global effort to produce meat sustainably. The news reflects a positive stride in making meat production more environmentally friendly, diverse, and secure.

Source: Food Safety News

Reach out to Fresh Group Food Safety And quality Consulting for any inquiries related to food quality and safety.